Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,736 public trials 631 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)

NCT00163462

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Altana Pharma/Nycomed Campinas - SP, Brazil
  • Altana Pharma/Nycomed Curitiba-PR, Brazil
  • Altana Pharma/Nycomed Florianópolis-SC, Brazil
  • Altana Pharma/Nycomed Porto Alegre-RS, Brazil
View all 57 locations
View Trial Details
Completed

To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)

NCT00659841

Conditions
Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations
  • Altana/Nycomed Austin, Texas, United States
  • Altana/Nycomed Austin, Texas, United States
  • Altana/Nycomed Kerrville, Texas, United States
  • Altana/Nycomed New Braunfels, Texas, United States
View Trial Details
Completed

To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)

NCT00659750

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • Altana/Nycomed Encinitas, California, United States
  • Altana/Nycomed Long Beach, California, United States
  • Altana/Nycomed Los Angeles, California, United States
  • Altana/Nycomed Mission Viejo, California, United States
View all 23 locations
View Trial Details
Completed

The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)

NCT00076076

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • ALTANA Pharma Cities in Alabama, Alabama, United States
  • ALTANA Pharma Cities in Arizona, Arizona, United States
  • ALTANA Pharma Cities in Arkansas, Arkansas, United States
  • ALTANA Pharma Cities in California, California, United States
View all 41 locations
View Trial Details
Completed

Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)

NCT00163527

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • ALTANA Pharma Cities in Georgia, Georgia, United States
  • ALTANA Pharma Cities in Austria, Austria
  • ALTANA Pharma Cities in Croatia, Croatia
  • ALTANA Pharma Cities in the Czech Repulik, Czechia
View all 24 locations
View Trial Details
Completed

Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)

NCT00163319

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Altana Pharma/Nycomed Brussels, Belgium
  • Altana Pharma/Nycomed Brussels, Belgium
  • Altana Pharma/Nycomed Brussels, Belgium
  • Altana Pharma/Nycomed Halen, Belgium
View all 89 locations
View Trial Details

Related conditions